These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25814516)

  • 1. Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    Hofman MS; Michael M; Kashyap R; Hicks RJ
    J Nucl Med; 2015 Jun; 56(6):968-9. PubMed ID: 25814516
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
    Garin E; Edeline J
    J Nucl Med; 2015 Jun; 56(6):969. PubMed ID: 25908828
    [No Abstract]   [Full Text] [Related]  

  • 3. Is 18F-Fluorodeoxyglucose the Tracer of Choice for Functional Imaging of Neuroendocrine Tumors Grade 3? A Case Report.
    Lorusso M; Inzani F; Castaldi P; Menghi R; Schinzari G; Rindi G; Rufini V
    Pancreas; 2018 Apr; 47(4):e20-e22. PubMed ID: 29521949
    [No Abstract]   [Full Text] [Related]  

  • 4. Can PET/CT guide the personalized treatment of patients with gastroenteropancreatic neuroendocrine neoplasms?
    Schillaci O
    J Nucl Med; 2014 Nov; 55(11):1757-8. PubMed ID: 25342386
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.
    Panagiotidis E; Bomanji J
    PET Clin; 2014 Jan; 9(1):43-55. PubMed ID: 25029933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers.
    Jadvar H
    Semin Nucl Med; 2012 Jul; 42(4):247-54. PubMed ID: 22681673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.
    Bahri H; Laurence L; Edeline J; Leghzali H; Devillers A; Raoul JL; Cuggia M; Mesbah H; Clement B; Boucher E; Garin E
    J Nucl Med; 2014 Nov; 55(11):1786-90. PubMed ID: 25286923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of Extramedullary Plasmacytomas Involving Lymph Nodes and Pancreas Revealed by 68Ga-DOTATATE and 18F-FDG PET/CT.
    Pan Q; Luo Y; Li J; Zhang S; Li F
    Clin Nucl Med; 2018 Dec; 43(12):936-938. PubMed ID: 30179917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
    Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours.
    Giammarile F; Billotey C; Lombard-Bohas C; Le Bars D; Bournaud C; Masson S; Walter T; Houzard C; Scoazec JY; Hervieu V; Vuillez JP; Cornu C; Janier M; Borson-Chazot F
    Nucl Med Commun; 2011 Feb; 32(2):91-7. PubMed ID: 21076344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours.
    Kashyap R; Hofman MS; Michael M; Kong G; Akhurst T; Eu P; Zannino D; Hicks RJ
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):176-85. PubMed ID: 25209134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
    Minn H; Kemppainen J; Kauhanen S; Forsback S; Seppänen M
    PET Clin; 2014 Jan; 9(1):27-36. PubMed ID: 25029931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-tektrotyd SPECT/MRI in the diagnosis of a gastroenteropancreatic neuroendocrine tumor.
    Zandieh S; Gambini JP; Haller J; Rodrigues M
    Clin Nucl Med; 2012 Apr; 37(4):e84-5. PubMed ID: 22391730
    [No Abstract]   [Full Text] [Related]  

  • 16. SNM 2012 image of the year.
    J Nucl Med; 2012 Oct; 53(10):23N. PubMed ID: 23028181
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
    Adkins J; Lu Y
    Clin Nucl Med; 2019 Mar; 44(3):257-258. PubMed ID: 30624276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Incidental Uptake of 18F-Choline at PET/CT in Gastric Neuroendocrine Tumor.
    Evangelista L; Cassarino G; Capobianco D; Povolato M; Battista S; Rensi M
    Clin Nucl Med; 2021 Apr; 46(4):e238-e239. PubMed ID: 33031248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latest Advances in Peptide Receptor Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors.
    Hindié E; Baudin E; Hicks RJ; Taïeb D
    J Nucl Med; 2023 Apr; 64(4):522-524. PubMed ID: 36604184
    [No Abstract]   [Full Text] [Related]  

  • 20. PET-Based Molecular Imaging in Designing Personalized Management Strategy in Gastroenteropancreatic Neuroendocrine Tumors.
    Basu S; Ranade R; Ostwal V; Shrikhande SV
    PET Clin; 2016 Jul; 11(3):233-41. PubMed ID: 27321028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.